Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
lin-28 homolog B | 0.556 | 0.654 | 0.56 |
|
disease | 0.900 | None | 1.000 | 11 | 2 | 2012 | 2020 | ||||||||
|
paired like homeobox 2B | 0.565 | 0.731 | 0.94 |
|
disease | 0.800 | None | 0.897 | 56 | 2 | 2004 | 2020 | ||||||||
|
MYCN proto-oncogene, bHLH transcription factor | 0.454 | 0.808 | 0.89 |
|
disease | 0.700 | None | 0.971 | 932 | 3 | 1984 | 2020 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
disease | 0.700 | None | 0.957 | 180 | 5 | 2000 | 2020 | ||||||||
|
LIM domain only 1 | 0.623 | 0.538 | 0.64 |
|
disease | 0.700 | None | 1.000 | 15 | 6 | 2011 | 2020 | ||||||||
|
HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 | 0.601 | 0.692 | 6.1E-06 |
|
disease | 0.610 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.600 | None | 0.984 | 62 | 0 | 1985 | 2019 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.600 | None | 0.933 | 13 | 0 | 1988 | 2016 | ||||||||
|
BRCA1 associated RING domain 1 | 0.597 | 0.538 | 1.4E-24 |
|
disease | 0.500 | None | 1.000 | 12 | 7 | 2009 | 2019 | ||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
disease | 0.480 | None | 1.000 | 8 | 1 | 2004 | 2018 | ||||||||
|
kinesin family member 1B | 0.516 | 0.808 | 1.00 |
|
disease | 0.480 | None | 0.875 | 6 | 1 | 1996 | 2014 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.450 | None | 1.000 | 5 | 3 | 2006 | 2017 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.400 | None | 0.955 | 176 | 8 | 1988 | 2019 | ||||||||
|
tyrosine hydroxylase | 0.462 | 0.885 | 1.7E-06 |
|
disease | 0.400 | None | 0.950 | 59 | 2 | 1989 | 2018 | ||||||||
|
neurotrophic receptor tyrosine kinase 1 | 0.422 | 0.808 | 2.0E-06 |
|
disease | 0.400 | None | 1.000 | 48 | 1 | 1992 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.400 | None | 0.943 | 34 | 0 | 1989 | 2018 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.400 | None | 0.880 | 24 | 0 | 1995 | 2014 | ||||||||
|
TNF superfamily member 10 | 0.413 | 0.885 | 0.13 |
|
disease | 0.400 | None | 1.000 | 16 | 0 | 1999 | 2019 | ||||||||
|
neurotrophic receptor tyrosine kinase 2 | 0.479 | 0.808 | 1.00 |
|
disease | 0.400 | None | 1.000 | 15 | 0 | 1994 | 2019 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.400 | None | 1.000 | 14 | 0 | 1993 | 2018 | ||||||||
|
chromodomain helicase DNA binding protein 5 | 0.604 | 0.500 | 1.00 |
|
disease | 0.400 | None | 1.000 | 14 | 0 | 2003 | 2016 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.400 | None | 1.000 | 13 | 1 | 2001 | 2020 | ||||||||
|
PTEN induced kinase 1 | 0.516 | 0.769 | 1.9E-10 |
|
disease | 0.400 | None | 1.000 | 11 | 2 | 2006 | 2019 | ||||||||
|
aurora kinase A | 0.475 | 0.731 | 0.87 |
|
disease | 0.400 | None | 0.917 | 11 | 2 | 1998 | 2019 | ||||||||
|
ATRX chromatin remodeler | 0.452 | 0.808 | 1.00 |
|
disease | 0.400 | None | 1.000 | 10 | 0 | 2012 | 2019 |